Generated with Avocode.
Line 2
Line 3
AI Insights to Impact:
Virtual Panel Discussion with Drs Kumar, Heit and Ms Philpot
Tuesday, December 10, 4:30 PM PST
Reserve Your Spot
Rapid U Login
Customer Support
UnitedStates
+1 650 388 9767 ext 2
UK
+44 330 094 5547
France
+33 1 87 65 03 49
Brazil
+55 13 4040 4298
Austraila
+61 2 8074 3445
Japan
+81 34 520 3242
Email Support
Contact
Sales
Media
Products & Solutions
Stroke
Why RapidAI for Stroke
PRODUCTS
Rapid NCCT
Rapid ICH
Rapid Hyperdensity
Rapid SDH
Rapid ASPECTS
Rapid Hypodensity
Rapid CTA
Rapid LVO
Rapid CTP
Rapid MRI
Rapid Workflow for Stroke
SOLUTIONS
AngioFlow by RapidAI
Aneurysm
PRODUCTS
RapidAI for Aneurysm
Pulmonary Embolism
Why RapidAI for PE
Products
Rapid PE
Analytics
PRODUCTS
RapidAI Insights
Clinical Trial Solutions
PRODUCTS
Rapid for Trials
Company
About RapidAI
Leadership
Partners
Careers
Services & Training
Implementation and Technical Support
Rapid U
Learn More About Rapid U
OFFERINGS
On Demand Learning
Instructor Led Training (ILT)
CE Credits
Advanced Services
Learn More About Advanced Services
OFFERINGS
RapidAI EMR Integration
Workflow Optimization and Training
RapidAI Custom Insights
Resources
RapidAI Resources
Rapid Hero Stories
Publications
Reimbursements
Clinical Trials
Clinical Results
RapidAI Blog
FAQ
News & Events
In the News
Press Releases
Events
Webinars
Products & Solutions
Stroke
Why RapidAI for Stroke
Rapid NCCT
Rapid ICH
Rapid Hyperdensity
Rapid SDH
Rapid ASPECTS
Rapid Hypodensity
Rapid CTA
Rapid LVO
Rapid CTP
Rapid MRI
Rapid Workflow for Stroke
AngioFlow by RapidAI
Aneurysm
Rapid for Aneurysm
Pulmonary Embolism
Why RapidAI for PE
Rapid PE
Analytics
RapidAI Insights
Clinical Trial Solutions
Rapid for Trials
Company
About RapidAI
Leadership
Partners
Careers
Services & Training
Implementation and Technical Support
Rapid U
On Demand Learning
Instructor Led Training (ILT)
CE, CME Credits
Advanced Services
RapidAI EMR Integration
Workflow Optimization and Training
RapidAI Custom Insights
Resources
RapidAI Resources
Rapid Hero Stories
Publications
Reimbursements
Clinical Trials
Clinical Results
RapidAI Blog
FAQ
News & Events
In the News
Press Releases
Events
Webinars
Press Releases
RapidAI
News & Events
Press Releases
WORLDWIDE MOMENTUM IS BUILDING
RapidAI is Making Big Strides
Learn about our latest happenings, check back often.
May 6, 2024
RapidAI Secures FDA Clearance for Perfusion Imaging in the Angiography Suite
February 12, 2024
RapidAI Announces Late-Breaking Abstract Simultaneously Published in NEJM; Highlights Key Data Revealed at ISC 2024
February 6, 2024
RapidAI to Enter ISC 2024 Showcasing Extensive Research and Unparalleled Industry Leadership
December 12, 2023
RapidAI Named to the 2023 CB Insights’ Digital Health 50 List
November 27, 2023
RapidAI Announces a Series of Industry Firsts – Unique Rapid Edge Cloud Platform, Breakthrough AI Non-Contrast CT Suite, International Expansion in Japan
November 9, 2023
RapidAI Receives FDA Clearance Of AI Module For Detection Of Hemispheric Subdural Hematomas
October 24, 2023
Texas County Memorial Hospital Goes Live with RapidAI to Enhance Neurovascular Decision Making and Rural Stroke Care
July 27, 2023
RapidAI Announces $75 Million Growth Investment Led by Vista Credit Partners
May 18, 2023
National University Hospital is first in Singapore to adopt RapidAI software that has been clinically validated in multi-site clinical trials
May 3, 2023
RapidAI Wins MedTech Breakthrough Award for Best New Imaging Solution
April 18, 2023
RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product
March 23, 2023
The Brain Aneurysm Foundation (BAF) Welcomes RapidAI’s Carolina Maier, PhD to Board of Directors
February 22, 2023
RapidAI Enhances Pulmonary Embolism Care Solution with FDA 510(k) Clearance for Rapid RV/LV
November 9, 2022
Rapid ICH Receives New FDA Clearance with Highest Sensitivity and Specificity on the Market
September 12, 2022
RapidAI Applauded by Frost & Sullivan for Delivering Quality Care Quickly and Securely With Its RapidAI Platform
July 21, 2022
RapidAI Receives FDA Clearance for Rapid Hyperdensity
May 24, 2022
RapidAI Receives FDA 510(k) Clearance for Pulmonary Embolism Triage & Notification
April 6, 2022
RapidAI Announces Amit Phadnis as New Chief Innovation and Technology Officer
January 31, 2022
RapidAI Announces Karim Karti as New CEO
September 23, 2021
RapidAI Receives TFDA Approval for Commercial Use
September 20, 2021
With support from RapidAI, Latin American hospitals receive Quality Stroke Care Certification to increase stroke treatment quality
August 19, 2021
RapidAI Achieves Record Momentum Amid Demand for Improved Clinical Decision Making and Patient Workflow
June 24, 2021
RapidAI Launches Rapid Workflow for Pulmonary Embolism (PE)
June 8, 2021
RapidAI Announces New Continuing Education Credits
May 20, 2021
RapidAI Unveils Prehospital Solution to Optimize Cross-Team Workflow and Improve Patient Care
May 6, 2021
Worldwide Leader in Cerebrovascular Imaging Unveils Expansion of First Comprehensive Stroke Analytics Solution
April 8, 2021
RapidAI Named Exclusive Advanced Neuroimaging Partner for the WSO and SIECV Stroke Center Certification Program in Latin America
February 24, 2021
RapidAI Breaks New Ground and Expands AI-powered Vascular Imaging Globally
February 10, 2021
RapidAI Acclaimed by Frost & Sullivan for Its AI-powered Modular Stroke Platform
February 4, 2021
RapidAI Cleared in Argentina
January 21, 2021
RapidAI Enhancing Stroke Care Across Australia
January 13, 2021
RapidAI Receives 2020 Global Company of the Year Award
November 12, 2020
RapidAI Celebrates International Adoption of AI-Powered Stroke Care
November 10, 2020
Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism
October 1, 2020
RapidAI Among the First Stroke Imaging Companies with Software Approved for Medicare New Technology Add-on Payment
September 17, 2020
RapidAI Announces $25 Million in Series B Funding
September 10, 2020
RapidAI Launches Rapid Web App, Receives ISO 27001 Certification
August 13, 2020
RapidAI Receives FDA Clearance of Rapid LVO
July 28, 2020
RapidAI Celebrates One-Millionth Scan
July 7, 2020
Rapid ASPECTS is First Ever Neuroimaging Solution to Receive CADx Clearance from the FDA
June 16, 2020
Leader in Stroke Imaging Introduces RapidAI Insights
June 9, 2020
RapidAI Acquires EndoVantage
February 18, 2020
RapidAI Introduces Technology Partner Program to Bring RapidAI Technology to more Hospital Environments
February 18, 2020
The Innovator in AI Enhanced Stroke Imaging Officially Becomes RapidAI
January 23, 2020
Rapid Celebrates Record-Breaking Year in Stroke Care
December 17, 2019
Rapid Advanced Medical Imaging for Stroke Now Installed in Vietnam
November 25, 2019
Ambra Health Announces Partnership with RAPID
October 29, 2019
Rapid Releases New Stroke Imaging Trends For World Stroke Day
October 21, 2019
Rapid Platform Expands to Address Hemorrhagic Stroke
July 8, 2019
Rapid receives registration approval in Japan
June 19, 2019
International approval update
June 18, 2019
Rapid now available for use in Mexico
May 20, 2019
iSchemaView Launches Rapid U
May 15, 2019
Data Suggests New Guidelines in Stroke Care Have Led to Record Numbers of Patients Treated
April 9, 2019
RAPID™ now approved for use in Israel
March 6, 2019
Dr. Gregory W. Albers Receives the Distinguished Clinical Research Achievement Award
February 28, 2019
iSchemaView Launches Rapid™ ANGIO
February 21, 2019
iSchemaView’s Rapid™ Approved for Use in Brazil
February 6, 2019
iSchemaView’s Rapid™ Imaging Platform Chosen for Patient Selection in TIMELESS Trial
February 4, 2019
Pulsara and iSchemaView Unveil New Rapid Integration
January 31, 2019
iSchemaView Introduces New Mobile and Notification Platform Features Across Its Family of Rapid Products
January 22, 2019
iSchemaView and NeuroLogica Team Up to Mobilize Stroke Care Worldwide
January 15, 2019
FDA Additionally Clears Rapid Imaging Platform to Select Acute Stroke Patients for Clot Removal
November 29, 2018
Rapid Imaging Platform Powers Mobile Stroke Units
November 14, 2018
iSchemaView Rapid™ Integrates with Join, Allm’s Medical Communications Platform
October 29, 2018
iSchemaView’s Rapid™ Adopted by More Than 700 Stroke Centers—Over 100 Percent Growth This Year
August 16, 2018
iSchemaView's Rapid™ Approved for Use in Canada
August 14, 2018
iSchemaView Rapid™ Technology Now Installed in More Than 500 Stroke Centers—Up 48% Since April
July 11, 2018
iSchemaView Brings Rapid™ Imaging Platform to Australia and New Zealand Through Exclusive Distributor, Diagnostic Imaging Australia
June 5, 2018
iSchemaView Completes MDSAP Audit, Moves to Expand Worldwide Adoption of Rapid™ Imaging Platform
May 15, 2018
iSchemaView Introduces Rapid™ ASPECTS
May 1, 2018
iSchemaView Receives FDA Clearance for Rapid CTA
April 24, 2018
iSchemaView Technology RAPIDly Adopted by Over 350 Stroke Centers
April 16, 2018
iSchemaView Names Don Listwin as CEO